Renaissance Technologies
NUTX

Renaissance Technologies’s Nutex Health NUTX Stock Holding History

Renaissance Technologies’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,300
Closed -$1.41M – 3775
2025
Q2 		$1.41M Buy
+11,300
New +$1.46M ﹤0.01% 2319
2025
Q1 		– Sell
-7,689
Closed -$244K – 3721
2024
Q4 		$244K Sell
7,689
-2,209
-22% -$63K ﹤0.01% 3106
2024
Q3 		$215K Buy
9,898
+4,208
+74% +$60.7K ﹤0.01% 3104
2024
Q2 		$33.9K Buy
5,690
+4,641
+442% +$33.5K ﹤0.01% 3329
2024
Q1 		$15K Sell
1,049
-2,096
-67% -$42.2K ﹤0.01% 3609
2023
Q4 		$85K Buy
3,145
+2,986
+1,878% +$93.1K ﹤0.01% 3343
2023
Q3 		$5K Sell
159
-1,431
-90% -$69K ﹤0.01% 3602
2023
Q2 		$101K Buy
+1,590
New +$136K ﹤0.01% 3468

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies's NUTX Position: Q3 2025 in Review

Renaissance Technologies sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 11,300 shares — an estimated $1.41M sold.

Renaissance Technologies first reported a position in NUTX in Q2 2023 and held it in 8 quarters. The position peaked at $1.41M in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

  • Renaissance Technologies reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 11,300 Nutex Health shares in Q3 2025, an estimated $1.41M.
  • Renaissance Technologies first reported a position in Nutex Health in Q2 2023 and held it in 8 quarters.
  • Renaissance Technologies's Nutex Health position peaked at $1.41M in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.